Core Viewpoint - AMSC plans to release its first quarter fiscal year 2025 financial results on July 30, 2025, followed by a conference call on July 31, 2025, to discuss recent accomplishments, financial results, and business outlook [1]. Company Overview - AMSC is a leading provider of megawatt-scale power resiliency solutions, focusing on optimizing power grid performance and enhancing the capabilities of naval fleets [1][3]. - The company offers various solutions, including Gridtec™ for grid reliability, Marinetec™ for naval protection systems, and Windtec™ for wind energy efficiency [3]. - Founded in 1987, AMSC is headquartered near Boston, Massachusetts, with operations across Asia, Australia, Europe, and North America [3]. Conference Call Details - Investors can access the live conference call on July 31, 2025, by dialing 1-844-481-2802 or 1-412-317-0675, starting 15 minutes before the scheduled time [2]. - A replay of the call will be available two hours after the event by dialing 1-877-344-7529 with the conference passcode 4291224 [2]. Contact Information - AMSC's Director of Communications is Nicol Golez, reachable at 978-399-8344 or Nicol.Golez@amsc.com [5]. - Investor relations can be contacted through Carolyn Capaccio, CFA, at 212-838-3777 or amscIR@allianceadvisors.com [5].

CLEARWATER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that financial results for the second quarter of fiscal year 2025 will be released after markets closes on Thursday, August 7th. Management will host a conference call at 4:30 p.m. Eastern Time on Thursday, August 7th, to di ...

BELTSVILLE, Md., July 24, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced the presentation of new preclinical data in a well-established model of osteogenesis imperfecta (OI) demonstrating that treatment with NC605, a novel anti-Siglec-15 antibody, achieved improved bone microarchitecture and reduced fracture incidence compared to anti- ...

ALISO VIEJO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the second quarter of 2025 after the market close on Thursday, August 7, 2025. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To participate in the conference call, pleas ...

Experienced mortgage lending and financial services leader joins to drive next phase of growthAUSTIN, Texas, July 24, 2025 (GLOBE NEWSWIRE) -- Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or the “Company”), an industry trailblazer in automotive lending enablement and risk analytics solutions for financial institutions, today announced the appointment of Massimo Monaco as Chief Financial Officer, effective August 18, 2025. Mr. Monaco brings over two decades of executive finance leadership experien ...

CHARLOTTE, N.C., July 24, 2025 (GLOBE NEWSWIRE) -- NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, announced today that it will release its second quarter 2025 financial results for the period ended June 30th, 2025, after the close of the market on Wednesday, August 6th, 2025. The Company will hold a related conference call on Thursday, August 7th, 2025, at 9:00 a.m. E.T. Participants on the call are asked to register ...

DUNKIRK, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- Lake Shore Bancorp, Inc. (“Lake Shore Bancorp”) (NASDAQ: LSBK), the holding company for Lake Shore Bank (the “Bank”), announced today that the Board of Directors declared a cash dividend of $0.09 per share on its outstanding common stock on July 23, 2025. The dividend is expected to be paid on August 13, 2025 to stockholders of record as of August 4, 2025. About Lake Shore Lake Shore Bancorp is the holding company of Lake Shore Bank, a New York chartered, com ...

Core Viewpoint - Phillips Edison & Company, Inc. (PECO) reported solid financial and operational results for Q2 2025, with an increase in full-year earnings guidance, reflecting strong demand in its grocery-anchored portfolio [1][3][21]. Financial Results - For Q2 2025, net income attributable to stockholders was $12.8 million, or $0.10 per diluted share, compared to $15.3 million, or $0.12 per diluted share in Q2 2024 [4]. - For the six months ended June 30, 2025, net income attributable to stockholders totaled $39.1 million, or $0.31 per diluted share, up from $32.9 million, or $0.27 per diluted share in the same period of 2024 [4]. - Nareit FFO for Q2 2025 increased by 9.8% to $86.0 million, or $0.62 per diluted share, compared to $78.4 million, or $0.57 per diluted share in Q2 2024 [5][6]. - Core FFO for Q2 2025 rose by 10.3% to $88.2 million, or $0.64 per diluted share, compared to $80.0 million, or $0.59 per diluted share in Q2 2024 [7]. Operational Highlights - Same-center NOI grew by 4.2% to $114.5 million in Q2 2025, compared to $109.8 million in Q2 2024 [8]. - The company reported a strong leased portfolio occupancy of 97.4% as of June 30, 2025, slightly down from 97.5% a year earlier [10]. - The company executed 276 leases totaling approximately 1.4 million square feet in Q2 2025, compared to 277 leases totaling approximately 1.7 million square feet in Q2 2024 [12]. Portfolio Overview - As of June 30, 2025, PECO's wholly-owned portfolio consisted of 303 properties totaling approximately 34.0 million square feet, an increase from 286 properties totaling approximately 32.6 million square feet a year earlier [9]. - The company completed $287 million in acquisitions to date in 2025, with a full-year acquisition guidance range of $350 million to $450 million [3][5]. Balance Sheet Highlights - As of June 30, 2025, PECO had approximately $972 million in total liquidity, including $9.2 million in cash and cash equivalents [18]. - The company's outstanding debt had a weighted-average interest rate of 4.4% and 95.0% of total debt was fixed-rate [19]. 2025 Guidance - PECO increased its 2025 earnings guidance, projecting net income per share of $0.61 to $0.64, Nareit FFO per share of $2.50 to $2.54, and Core FFO per share of $2.55 to $2.60 [21][22].

Core Viewpoint - Iovance Biotherapeutics, Inc. is set to report its second quarter and first half 2025 financial results and corporate updates on August 7, 2025, highlighting its focus on innovative TIL therapies for cancer patients [1][2]. Company Overview - Iovance Biotherapeutics aims to be a global leader in developing tumor infiltrating lymphocyte (TIL) therapies, utilizing the human immune system to target diverse cancer cells [3]. - The company's TIL platform has shown promising clinical data across various solid tumors, with Amtagvi being the first FDA-approved T cell therapy for a solid tumor indication [3]. Upcoming Events - Management will host a conference call and live audio webcast on August 7, 2025, at 4:30 p.m. ET to discuss the financial results and provide a corporate update [2]. - The live and archived webcast will be accessible through the company's website, with the archived version available for one year [2].

Company Announcement - Teads Holding Co. will release its second quarter 2025 results before the market opens on August 7, 2025, followed by a conference call at 8:30 a.m. Eastern Time to discuss the results and business outlook [1] Conference Call Details - The conference call can be accessed live by dialing 1-888-437-3179 for domestic callers and 1-862-298-0702 for international callers, with a replay available two hours after the call [2] - The replay can be accessed by dialing 1-877-660-6853 for domestic callers and 1-201-612-7415 for international callers, with the passcode 13754497, available until August 21, 2025 [2] Webcast Information - Interested parties can listen to a simultaneous webcast of the conference call by visiting the Investor Relations section of the company's website, with an online replay available shortly after the call [3] Company Overview - Teads is an omnichannel outcomes platform for the open internet, focusing on driving full-funnel results for marketers across premium media, leveraging predictive AI technology [4] - The company partners with over 10,000 publishers and 20,000 advertisers globally, employing nearly 1,800 people across more than 30 countries [4]